We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+14.21%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$987M
AUM Growth
+$120M
Cap. Flow
+$63.5M
Cap. Flow %
6.44%
Top 10 Hldgs %
5.22%
Holding
1,870
New
579
Increased
363
Reduced
419
Closed
480

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$6.71M
2
DXCM icon
DexCom
DXCM
+$6.59M
3
X
US Steel
X
+$6.1M
4
CMBT
CMB.TECH NV
CMBT
+$5.09M
5
SPLK
Splunk Inc
SPLK
+$4.85M

Top Sells

Rank Stock Value
1
GOOS
Canada Goose Holdings
GOOS
+$21.9M
2
STZ icon
Constellation Brands
STZ
+$9.52M
3
LUMN icon
Lumen
LUMN
+$7.13M
4
WY icon
Weyerhaeuser
WY
+$6.3M
5
FDX icon
FedEx
FDX
+$6.07M

Sector Composition

Rank Sector Weight
1 Healthcare 16.75%
2 Technology 15.19%
3 Consumer Discretionary 13.45%
4 Industrials 12.06%
5 Financials 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALG icon
351
Alamo Group
ALG
$2.02B
$892K 0.09%
8,924
+2,305
+35% +$208K
OI icon
352
O-I Glass
OI
$1.09B
$892K 0.09%
+46,974
New +$911K
NUVA
353
DELISTED
NuVasive, Inc.
NUVA
$891K 0.09%
15,686
-9,029
-37% -$480K
EFC
354
Ellington Financial
EFC
$1.65B
$884K 0.09%
+49,377
New +$829K
PDLI
355
DELISTED
PDL BioPharma, Inc.
PDLI
$884K 0.09%
237,513
-7,187
-3% -$24.3K
G icon
356
Genpact
G
$6.13B
$883K 0.09%
+25,102
New +$792K
OSK icon
357
Oshkosh
OSK
$9.47B
$883K 0.09%
+11,752
New +$868K
MED icon
358
Medifast
MED
$136M
$880K 0.09%
6,901
-8,093
-54% -$1.03M
BILI icon
359
Bilibili
BILI
$7.81B
$877K 0.09%
+46,300
New +$810K
JACK icon
360
Jack in the Box
JACK
$331M
$873K 0.09%
10,764
+5,142
+91% +$411K
ZAGG
361
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
$872K 0.09%
96,170
-9,120
-9% -$99.9K
ILMN icon
362
Illumina
ILMN
$29.3B
$871K 0.09%
2,880
+515
+22% +$150K
MLKN icon
363
MillerKnoll
MLKN
$1.61B
$871K 0.09%
24,767
+6,098
+33% +$213K
BKE icon
364
Buckle
BKE
$2.36B
$870K 0.09%
46,500
CROX icon
365
Crocs
CROX
$6.43B
$869K 0.09%
33,730
+18,657
+124% +$511K
TSCO icon
366
Tractor Supply
TSCO
$17.9B
$869K 0.09%
44,440
+4,180
+10% +$76K
ACOR
367
DELISTED
Acorda Therapeutics
ACOR
$869K 0.09%
545
+37
+7% +$66.7K
OSIS icon
368
OSI Systems
OSIS
$3.91B
$866K 0.09%
9,882
+4,953
+100% +$415K
ZWS icon
369
Zurn Elkay Water Solutions
ZWS
$8.6B
$865K 0.09%
+71,404
New +$888K
MANT
370
DELISTED
Mantech International Corp
MANT
$864K 0.09%
+15,985
New +$876K
HIG icon
371
Hartford Financial Services
HIG
$39.6B
$862K 0.09%
+17,331
New +$823K
ICUI icon
372
ICU Medical
ICUI
$4.16B
$862K 0.09%
3,600
DELL icon
373
Dell
DELL
$283B
$857K 0.09%
28,806
-170,862
-86% -$4.5M
LAD icon
374
Lithia Motors
LAD
$8.26B
$853K 0.09%
9,197
+4,148
+82% +$361K
ONDK
375
DELISTED
On Deck Capital, Inc.
ONDK
$852K 0.09%
157,186
+119,800
+320% +$759K

Similar funds

GSA Capital Partners's Q1 2019 Portfolio in Review

As of Q1 2019, GSA Capital Partners held 1,870 positions worth $987M, up 14% from $867M the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.

GSA Capital Partners deployed $63.5M of net new capital in Q1 2019, opening 579 new positions and adding to 363 existing holdings. Its largest new stake was DexCom: 187,420 shares worth $5.58M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Lumen, an estimated $7.13M trimmed.

  • GSA Capital Partners's largest Q1 2019 buy was DexCom: 187,420 shares worth $5.58M.
  • GSA Capital Partners added most to Biogen in Q1 2019, an estimated $6.71M increase.
  • GSA Capital Partners's biggest Q1 2019 reduction was Lumen, cutting an estimated $7.13M.
  • GSA Capital Partners fully exited Canada Goose Holdings in Q1 2019, selling an estimated $21.9M.
  • GSA Capital Partners's ten largest holdings make up 5.2% of its $987M portfolio in Q1 2019.
  • GSA Capital Partners opened 579 new positions and closed 480 in Q1 2019.
  • GSA Capital Partners's portfolio value rose 14% quarter-over-quarter to $987M.

Based on GSA Capital Partners's 13F filing for Q1 2019, filed 15 May 2019.